Sustainability is deep rooted in all our decision making
We always strive to do more in order to positively impact our patients consumers, employees, communities as well as our shareholders. We firmly believed that doing business with a conscience is integral in order to sustain our business success.
LATEST
News Updates
20 MARCH 2025
Pharmaniaga Berhad (Pharmaniaga) is moving forward with the implementation of its Regularisation Plan (RP) to exit its Practice Note 17 (PN17) status, following shareholders’ overwhelming approval of three key resolutions at the Group’s Extraordinary General Meeting (EGM) today.
28 FEBRUARY 2025
Pharmaniaga Berhad (Pharmaniaga) has sustained its growth momentum, delivering positive financial results for the financial year ended 31 December 2024 (FY2024). The Group achieved a Profit After Zakat and Taxation (PAT) of RM133.8 million, marking a significant turnaround from a Loss After Zakat and Taxation (LAT) of RM78.7 million in the previous year.
28 NOVEMBER 2024
Pharmaniaga Berhad (Pharmaniaga) ramps up its Going Green programme with the launch of its latest renewable energy initiative through Solar PV System Project in collaboration with Cenergi SEA Berhad (Cenergi).
26 NOVEMBER 2024
Demonstrating further progress in its strong recovery, Pharmaniaga Berhad (Pharmaniaga) today reported improved results for its third quarter ended 30 September 2024 (Q3 FY2024), with Profit After Tax (PAT) reaching RM101.3 million compared with a loss of RM49.0 million in the same quarter last year (Q3 FY2023).
10 OCTOBER 2024
Pharmaniaga Berhad (Pharmaniaga) is pleased to announce the appointment of Messrs Ernst & Young (EY) as its new external auditor, effective 9 October 2024. EY replaces Messrs PricewaterhouseCoopers (PwC), which has resigned following a formal written notice served to the Group on 20 September 2024.